Status:
UNKNOWN
A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
Lead Sponsor:
Hospital for Children and Adolescents, Finland
Conditions:
Kallmann Syndrome
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.
Detailed Description
Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror m...
Eligibility Criteria
Inclusion
- Kallmann syndrome
- Age 15 yrs or more
Exclusion
- Severe mental retardation
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00623116
Start Date
December 1 2007
End Date
December 1 2025
Last Update
February 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Children and Adolescents, Helsinki University Central Hospital
Helsinki, Finland, 00029 HUCH